GlassScriptPhysician profile
Thomas Kurian
NPI 1669587499
$1,871.35
in general payments reported to CMS, 2019-2025
19 companies · $651 in 2025
The $651 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $85.25 · 2021: $133 · 2022: $284 · 2023: $152 · 2024: $112 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.67 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $300.01 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Sphere-9 |
| Penumbra, INC. | $194.66 | 2023-2025 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.36 | 2022-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $145.11 | 2019-2025 | |
| Biotronik INC. | $141.81 | 2022-2023 | Orsiro Mission |
| E.R. Squibb & Sons, L.L.C. | $124.39 | 2023-2025 | Camzyos, Eliquis |
| Amgen INC. | $123.91 | 2019-2024 | Repatha |
| Abbott Laboratories | $115.02 | 2019-2024 | Cardiomems, Diamondback Coronary |
| Abiomed | $105.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $88.36 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $84.04 | 2019 | |
| Boston Scientific Corporation | $79.97 | 2021-2025 | Watchman Flx, General - Tachy |
| Pfizer INC. | $66.72 | 2019-2020 | |
| Novo Nordisk INC | $52.66 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $22.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $22.52 | 2024 | Arcalyst |
| Lundbeck LLC | $20.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.72 | 2019 | |
| Cardiovascular Systems INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kurian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.